Balanced news tone
News Sentiment
HSIC sentiment intelligence
Henry Schein Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
81/100 classification confidence.
directly relevant articles
high-authority source matches
-2.3% over one week, +3.9% over four weeks, trend active, and near fair-value range.
Henry Schein stock reflects steady healthcare distribution business
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Henry Schein stock reflects steady healthcare distribution business
Henry Schein stock provides investors exposure to a global distributor of dental and medical supplies and technology solutions. The company's business model is characterized by recurring demand for consumables driven by ongoing patient care and a mixed revenue stream from both co
- Tone
- Positive 74/100
- Event
- Earnings
- Published
- 16 Jul 2026 05:39
- Source
- Ad Hoc News
What to Expect From Henry Schein's Next Quarterly Earnings Report
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jul 2026 12:49
- Source
- Market source
Henry Schein stock holds steady as dental and medical distribution remains a core healthcare backbon
Henry Schein stock remains stable due to its essential role in dental and medical distribution, serving a broad base of healthcare professionals with recurring supplies and equipment. The company's business model is strengthened by integrating technology solutions like practice m
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 15 Jul 2026 02:05
- Source
- Ad-hoc-news.de
Henry Schein Inc. stock outperforms competitors on strong trading day
Henry Schein Inc. (HSIC) stock increased by 1.31% to $86.91 on Tuesday, outperforming the S&P 500 Index and the Dow Jones Industrial Average on a strong trading day. This marks the fourth consecutive day of gains for the company's stock. The positive performance occurred as the S
- Tone
- Positive 76/100
- Event
- Market update
- Published
- 14 Jul 2026 21:16
- Source
- MarketWatch
Henry Schein stock reflects steady health-care distribution business
Henry Schein stock offers investors exposure to a global distributor of dental and medical supplies, catering primarily to independent practitioners and small to mid-sized healthcare organizations. The company's diversified business model, encompassing dental, medical, and techno
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 14 Jul 2026 10:50
- Source
- Ad Hoc News
Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry
The medical supply industry is experiencing strong tailwinds in the second half of 2026, driven by resilient healthcare utilization, rising specialty care demand, and the adoption of digital technologies. Companies like McKesson, Cardinal Health, West Pharmaceutical Services, Ali
- Tone
- Positive 65/100
- Event
- Macro sensitivity
- Published
- 14 Jul 2026 07:39
- Source
- TradingView
Multi-year Support for Henry Schein Innovation Laboratory
The Medical University of South Carolina (MUSC) announced a multi-year in-kind contribution from Henry Schein, Inc., to advance the Henry Schein Innovation Laboratory at the MUSC James B. Edwards College of Dental Medicine. This investment will support the expansion of digital de
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 13 Jul 2026 13:08
- Source
- The Medical University of South Carolina
Is Henry Schein’s GoTu Staffing Integration Reshaping Its Services Efficiency Narrative (HSIC)?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 14:36
- Source
- simplywall.st
Is Now The Time To Look At Buying Henry Schein, Inc. (NASDAQ:HSIC)?
This article asks if Henry Schein, Inc. (NASDAQ:HSIC) is a good investment opportunity currently. It signals an analysis of whether the present time represents a favorable entry point for potential buyers of the stock.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jul 2026 08:38
- Source
- Moomoo
BMO Capital Maintains Henry Schein(HSIC.US) With Hold Rating, Raises Target Price to $85
BMO Capital has reiterated its "Hold" rating on Henry Schein (HSIC.US) and increased its target price for the stock to $85.00. This adjustment follows the company's Q1 2026 earnings report, where although earnings per share slightly missed estimates, revenue exceeded expectations
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 Jul 2026 08:08
- Source
- Moomoo
BMO Capital Initiates Henry Schein at Market Perform With $85 Price Target
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 09 Jul 2026 12:38
- Source
- MT Newswires
Henry Schein stock stays supported by steady dental demand
Henry Schein stock performance is closely linked to its role as a major distributor of dental and medical supplies. The company benefits from consistent demand for dental and medical services, strong margin discipline, and growth through technological solutions. Henry Schein's bu
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 09 Jul 2026 12:13
- Source
- Ad-hoc-news.de
Henry Schein Inc. stock underperforms Wednesday when compared to competitors
Shares of Henry Schein Inc. (HSIC) fell by 4.17% on Wednesday, closing at $83.22. This underperformance occurred during a generally difficult trading session, with the S&P 500 Index (SPX) dropping 0.28% and the Dow Jones Industrial Average (DJIA) declining by 1.09%. The stock's d
- Tone
- Negative 30/100
- Event
- Market update
- Published
- 08 Jul 2026 23:38
- Source
- MarketWatch
Henry Schein (HSIC) Coverage Initiated by BMO Capital with Marke
BMO Capital has initiated coverage on Henry Schein Inc (HSIC) with a Market Perform rating and an $85 price target, citing investor uncertainty following a recent CEO change. The firm emphasizes that the company's value creation strategy will largely depend on its operational per
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 08 Jul 2026 22:45
- Source
- GuruFocus
Henry Schein focuses on dental and medical distribution as investors watch sector trends
Henry Schein is a major distributor of dental and medical supplies, with its stock attracting investor interest due to its focus on healthcare supply and distribution in the U.S. The company provides a wide range of products, from consumables to advanced equipment, and also offer
- Tone
- Positive 72/100
- Event
- Macro sensitivity
- Published
- 08 Jul 2026 10:28
- Source
- AD HOC NEWS
Henry Schein (HSIC) Could Be 2% Undervalued Following GoTu Partnership
Henry Schein (HSIC) recently partnered with GoTu Technology and was removed from the Russell 1000 Dynamic Index, leading to improved share price momentum. While the company is considered "1.6% Undervalued" with a fair value of $88.07, its current P/E ratio of 25x appears expensiv
- Tone
- Positive 65/100
- Event
- Deals and strategy
- Published
- 07 Jul 2026 23:07
- Source
- Sahm
Henry Schein Inc focuses on dental and medical supply distribution as investors watch long term fund
Henry Schein Inc is recognized as a global leader in dental and medical product distribution, with investors closely monitoring its established business model and long-term financial health. The company serves office-based healthcare practitioners by providing a wide array of pro
- Tone
- Positive 71/100
- Event
- Macro sensitivity
- Published
- 07 Jul 2026 14:48
- Source
- AD HOC NEWS
Is Henry Schein (HSIC) Stock Undervalued Right Now?
Henry Schein (HSIC) stock appears undervalued, holding a Zacks Rank #2 (Buy) and a Value grade of A. The company's valuation metrics, including its P/E, P/B, P/S, and P/CF ratios, are all favorable when compared to its industry averages, suggesting potential for profit. Given its
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 07 Jul 2026 14:08
- Source
- Market source
Evercore ISI Adjusts Price Target on Henry Schein to $100 From $90
Evercore ISI has increased its price target for Henry Schein (NASDAQ: HSIC) to $100 from $90. The analyst firm maintains an Outperform rating on the stock. This adjustment reflects Evercore ISI's updated outlook for the company.
- Tone
- Positive 74/100
- Event
- Analyst action
- Published
- 07 Jul 2026 13:08
- Source
- Moomoo
Henry Schein stock keeps the focus on guidance and operations.
Henry Schein stock remains focused on its health-care distribution model, emphasizing operational execution, margins, and demand across its customer base. The company, a U.S.-listed dental and medical supplies supplier, thrives on recurring purchases and established customer rela
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 07 Jul 2026 06:38
- Source
- AD HOC NEWS
smartIPR Now Available from Henry Schein Orthodontics
Henry Schein Orthodontics (HSO) has announced the availability of the smartIPR advanced interproximal reduction system in the United States, through an exclusive distribution agreement with Eversmile. This system utilizes a vibrating handpiece with non-rotating, lubricated smart
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 06 Jul 2026 20:26
- Source
- Dentistry Today
Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth in the Medical Distribution Sector with a 1.89% Upside
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 06 Jul 2026 09:18
- Source
- DirectorsTalk Interviews
Henry Schein (HSIC) price target increased by 12.37% to 90.80
The article reports that the price target for Henry Schein (HSIC) has been increased by 12.37% to $90.80. No further details are provided in this brief update.
- Tone
- Positive 78/100
- Event
- Analyst action
- Published
- 05 Jul 2026 09:07
- Source
- MSN
Henry Schein (HSIC) Stifel Jaws & Paws Conference 2026 Summary
This article summarizes Henry Schein's (HSIC) presentation at the Stifel Jaws & Paws Conference 2026, highlighting the company's strategic priorities, market trends, and product innovation. Key focuses include simplifying the business, driving growth through technology and own br
- Tone
- Positive 74/100
- Event
- Market update
- Published
- 03 Jul 2026 18:08
- Source
- Quartr
Henry Schein focuses on dental and medical supplies as a diversified health-care distributor
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 16:23
- Source
- Ad Hoc News
GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 30 Jun 2026 13:00
- Source
- PR Newswire
Henry Schein teams up with GoTu to ease dental staffing gaps
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Stock Titan
Is Henry Schein Stock Underperforming the Nasdaq?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Market source
Henry Schein: Smile Because The Upside Isn't Over
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 21 Jun 2026 07:00
- Source
- Seeking Alpha
Henry Schein Stock - Saturday deep dive into the business model
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jun 2026 07:00
- Source
- Ad Hoc News